Vigabatrin Oral Solution shortage
Vigabatrin Oral Solution is currently listed in shortage by the FDA. The FDA lists 1 affected product. This page was last refreshed from FDA data on Sep 23, 2026.
Pyros Pharmaceuticals is stopping production of vigabatrin oral solution, and this change may be permanent. Other makers have not reported a shortage and still list vigabatrin oral solution (powder for solution) at the same strength.
Don’t stop or change your therapy on your own — talk with your prescriber about the plan that fits you, and ask your pharmacist what’s actually available (see options).
Do you take this drug? See the ‘What to do’ recommendation from Dr. Brian Staiger, PharmD →What’s in shortage — at a glance
These figures count only the manufacturers that reported this shortage to the FDA — not every company that makes Vigabatrin Oral Solution. Other makers that haven’t reported a problem are shown in the green card below.
Shortage timeline
-
Oct 16, 2025Currently in shortage1 of 1 product affected.
-
Oct 16, 2025First reported to the FDA1 product first listed.
Built from FDA posting and update dates. The end date FDA publishes is the posting/update date, not a true resolution date, so durations are approximate.
What exactly is on backorder — by manufacturer
Manufacturer: Pyros Pharmaceuticals, Inc. 📞 763-315-2000 1 NDC click to expand
| Status | NDC / product | Strength | Availability | Related information | Reason |
|---|---|---|---|---|---|
| To Be Discontinued | Vigpoder, Oral Solution, 50 mg/1 mL (NDC 80789-117-50) | — | — | Discontinuation of the manufacture of the drug | — |
These rows are manufacturer reports to the FDA for Vigabatrin Oral Solution — they do not necessarily cover every manufacturer that makes this drug. A company appears here only if it told the FDA it has a supply problem, so other makers may still have stock. That’s the basis for the Where else can I get Vigabatrin Oral Solution? options further down this page.
Why is Vigabatrin Oral Solution in shortage?
Pyros Pharmaceuticals has let the FDA know that they are permanently stopping the manufacturing of their vigabatrin oral solution, Vigpoder, in the 50 mg/1 mL strength. No specific reason was shared publicly for why they made this decision — just that they are discontinuing production of this particular product.
It's worth knowing that this report only covers Pyros Pharmaceuticals and their version of this medication. It doesn't mean vigabatrin oral solution is disappearing from every manufacturer out there — this is specific to Vigpoder (50 mg/1 mL) from Pyros.
Based on the manufacturer-reported reason(s) and notes on file with the FDA for Vigabatrin Oral Solution, summarized in plain English by HelloPharmacist. A drug can be short for more than one reason, and the FDA updates these as manufacturers report changes.
What should I do if I take Vigabatrin Oral Solution?
Vigabatrin oral solution is currently on the FDA shortage list, and I want to walk you through what this means for you.
The only strength on this record, 50 mg/1 mL, does not have an available source right now. The reason reported is that the manufacturer, Pyros Pharmaceuticals, is discontinuing production of its product (Vigpoder). Because this is listed as a discontinuation, this particular supply problem may be permanent — so a conversation with your prescriber is the right next step rather than something to handle alone.
The good thing to know is that this report reflects only one manufacturer. Several other companies make the same medicine, vigabatrin, in the same 50 mg/mL strength — for example products from Upsher-Smith, Actavis, Camber, Dr. Reddy's, Lundbeck (Sabril), and others. Your pharmacy may be able to source one of these, though it may not be in local stock today.
Here is what I'd suggest, in order:
- Do not stop, skip, or change your dose on your own.
- Ask your pharmacy to check wholesalers and other manufacturers for the same medicine.
- Talk with your prescriber or pharmacist about which option fits you, since this product is being discontinued.
Manufacturer contact numbers are listed on this page for reference; pharmacies usually make these calls.
- Don’t stop or change the medication on your own — talk to your prescriber first.
- If this is part of an ongoing or essential regimen (for example HIV treatment or prevention, seizure, heart, transplant, diabetes or mental-health medicines), do not skip or ration doses — contact your pharmacist or prescriber right away to arrange continued supply before you run out.
- Ask your pharmacy to check other manufacturers, strengths, package sizes, and nearby stores.
- Ask your prescriber whether a different strength, formulation, or the brand/generic version is appropriate.
Uses, dosing, side effects, prices, and the complete FDA label — written in plain English and pharmacist-reviewed.
Where else can I get Vigabatrin Oral Solution?
FDA shortages are manufacturer-reported — a company only shows up on the shortage list if it told the FDA it has a supply problem, so not every maker of Vigabatrin Oral Solution is necessarily short. Below we pull together the other still-marketed options that are not reported in shortage: the same medicine from manufacturers that haven’t reported a problem, and alternative dosage forms. These may still be out of stock at your pharmacy, and only your prescriber or pharmacist can decide what’s right for you.
Same medicine, other manufacturers (not reported short)
Same active ingredient, dosage form & route as the shortage (matched on the FDB HICL ingredient code), from makers that have not filed a shortage with the FDA:
| Product | Strength | Form / route | Manufacturer | NDC |
|---|---|---|---|---|
| Vigadrone | VIGABATRIN 50 mg/mL | Powder, For Solution · Oral | Upsher-Smith Laboratories, LLC | 00245-0556-50 |
| Vigabatrin | VIGABATRIN 50 mg/mL | Powder, For Solution | Actavis Pharma, Inc. | 00591-3955-50 |
| Vigabatrin For Oral Solution | VIGABATRIN 50 mg/mL | Powder, For Solution · Oral | Camber Pharmaceuticals, Inc. | 31722-0009-50 |
| Vigabatrin | VIGABATRIN 50 mg/mL | Powder, For Solution · Oral | Dr. Reddys Laboratories Inc., | 43598-0697-50 |
| Vigabatrin | VIGABATRIN 50 mg/mL | Powder, For Solution · Oral | Par Health USA, LLC | 49884-0358-03 |
| Vigabatrin | VIGABATRIN 500 mg/1 | Powder, For Solution · Oral | Aurobindo Pharma Limited | 59651-0366-50 |
| Sabril | VIGABATRIN 50 mg/mL | Powder, For Solution · Oral | Lundbeck Pharmaceuticals LLC | 67386-0211-65 |
| Vigabatrin | VIGABATRIN 50 mg/mL | Powder, For Solution · Oral | Ascend Laboratories, LLC | 67877-0674-63 |
| Vigabatrin | VIGABATRIN 500 mg/mL | Powder, For Solution · Oral | Cipla USA, Inc. | 69097-0964-53 |
Alternative dosage forms of Vigabatrin
A different form of the same drug (for example a solution when capsules are short). A form change is a clinical decision — ask your prescriber:
Therapeutic equivalents & pricing 1 productclick to expand
Orange Book–rated equivalents of the affected strengths, with the latest NADAC price (a federal retail-acquisition benchmark, not your copay) and an evidence-based availability label. Cheapest first.
| Product | Manufacturer | Package | NADAC $/unit | AB rating | Availability |
|---|---|---|---|---|---|
| Vigpoder 50 mg/mL | Pyros | 50 packets | — | AA | Discontinued |
Equivalents share the same ingredient, strength, dosage form and route; an AB rating means the FDA considers them substitutable. NADAC is a national retail-pharmacy acquisition benchmark from CMS — not what you pay. Availability is inferred from recent pricing, not a stock check.
Other drugs in the same treatment class
These are different medicines — not other versions of Vigabatrin Oral Solution — that fall in the same broad treatment class (anticonvulsants) . They are not automatic substitutes: they can differ in how they work, dosing, effectiveness, side effects and what they’re approved to treat. Do not switch on your own. This list is for information only — ask your prescriber or pharmacist whether any of them is appropriate for you.
Identity & classification
Where does this data come from?
Other neurology shortages
Vigabatrin Oral Solution shortage FAQs
Is Vigabatrin Oral Solution in shortage?
Which products are affected?
When will Vigabatrin Oral Solution be available again?
Can I still get Vigabatrin somewhere?
What should I do if I take Vigabatrin Oral Solution?
Still have a question about the Vigabatrin Oral Solution shortage?
Ask a pharmacist about this shortage →View Vigabatrin Oral Solution on the FDA drug-shortage database →
Where does this data come from?
/drug/shortages) — drug, manufacturer & contact, NDC/product, status, availability, reason, therapeutic category and posting/update dates. Current / To Be Discontinued = active; Resolved is kept for history. The Supply-Risk rating is assessed per active ingredient and adds the FDA NDC Directory (still-marketed manufacturers by ingredient & form); same-medicine and equivalent products use First Databank classification + CMS NADAC pricing; Medicaid use + most-affected states come from CMS Medicaid State Drug Utilization Data. Reference only — confirm current status with the manufacturer or FDA before acting on it.